Natural selection of tumor variants in the generation of “tumor escape” phenotypes
Top Cited Papers
- 1 November 2002
- journal article
- review article
- Published by Springer Nature in Nature Immunology
- Vol. 3 (11), 999-1005
- https://doi.org/10.1038/ni1102-999
Abstract
The idea that tumors must “escape” from immune recognition contains the implicit assumption that tumors can be destroyed by immune responses either spontaneously or as the result of immunotherapeutic intervention. Simply put, there is no need for tumor escape without immunological pressure. Here, we review evidence supporting the immune escape hypothesis and critically explore the mechanisms that may allow such escape to occur. We discuss the idea that the central engine for generating immunoresistant tumor cell variants is the genomic instability and dysregulation that is characteristic of the transformed genome. “Natural selection” of heterogeneous tumor cells results in the survival and proliferation of variants that happen to possess genetic and epigenetic traits that facilitate their growth and immune evasion. Tumor escape variants are likely to emerge after treatment with increasingly effective immunotherapies.Keywords
This publication has 106 references indexed in Scilit:
- Alterations of Fas-pathway genes associated with nodal metastasis innon-small cell lung cancerOncogene, 2002
- Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte ResponsesThe Journal of Experimental Medicine, 2001
- TGF-β Released by Apoptotic T Cells Contributes to an Immunosuppressive MilieuImmunity, 2001
- Recognition of autologous dendritic cells by human NK cellsEuropean Journal of Immunology, 1999
- Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICAScience, 1999
- Effect of interleukin‐10 on dendritic cell maturation and functionEuropean Journal of Immunology, 1997
- Implications for immunosurveillance of altered HLA class I phenotypes in human tumoursImmunology Today, 1997
- Clinical significance of the determination of angiogenic factorsEuropean Journal Of Cancer, 1996
- High frequency of altered HLA class I phenotypes in invasive breast carcinomasHuman Immunology, 1996
- Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40‐ligand) and TNF‐α, but strongly enhanced by interleukin‐10European Journal of Immunology, 1995